JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Ph I Dasatinib + Erlotinib in Recurrent MG
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 47
- Registration Number
- NCT00609999
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- Duke University
- Target Recruit Count
- 2
- Registration Number
- NCT00608140
- Locations
- 🇺🇸
Morehouse School of Medicine, Atlanta, Georgia, United States
🇺🇸Minnesota Heart Failure Network, Minneapolis, Minnesota, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study)
- Conditions
- Interventions
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 188
- Registration Number
- NCT00608491
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸University of Utah Health Sciences Center, Murray, Utah, United States
🇺🇸University of Vermont - Fletcher Allen Health Care, Burlington, Vermont, United States
A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic
- Conditions
- Interventions
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 151
- Registration Number
- NCT00606567
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
- Conditions
- Interventions
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Duke University
- Target Recruit Count
- 55
- Registration Number
- NCT00606541
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants
- Conditions
- Interventions
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 40
- Registration Number
- NCT00606437
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
DNA/RNA Analysis of Blood and Skeletal Muscle in Patients Undergoing Cardiac Resynchronization Therapy (CRT)
- Conditions
- First Posted Date
- 2008-01-25
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 30
- Registration Number
- NCT00600392
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
- Conditions
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 32
- Registration Number
- NCT00597493
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
A Phase I/Expansion Study of Dasatinib
- Conditions
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Duke University
- Target Recruit Count
- 30
- Registration Number
- NCT00598091
- Locations
- 🇺🇸
UNC Lineberger, Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
- Conditions
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2014-05-07
- Lead Sponsor
- Duke University
- Target Recruit Count
- 125
- Registration Number
- NCT00597402
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States